Study On Pharmaceutical Enterprises Selecting And Managing The CRO

In today's world, the characteristics of "high investment, high risk and long-period" have become increasingly prominent during the pharmaceutical enterprises' new drugs R&D. New drugs R&D's cost is increasing year by year, but the number of new drugs is obviously reduced. The traditional new drugs R&D's way is increasingly being challenged, and the concept of completing independently new drugs R&D's all stages is also outdated. Today, pharmaceutical enterprises need about 8 to 14 years and 800 to 1000 million dollars in costs to have developed an innovative drug. We all know innovative drug is the key that modern pharmaceutical enterprises can win in fierce market competition. In this case, the CRO come into the pharmaceutical industry, which can reduce new drugs R&D's cycle, save new drugs R&D's cost and has professional technical services. CRO is the english abbreviation of the "Contract Research Organization" . It is a academic or commercial scientific institution which provides the new drugs R&D's some technical services for modern pharmaceutical enterprises and two sides must sign one contract before they cooperate.With the rapid growth of global pharmaceutical outsourcing services, most pharmaceutical enterprises of the world are adapting to the trend of increasingly fine division. They have began to cooperate with CRO for the common development. Today, CRO has become an new international model of new drugs R&D and the nevitable choice of modern pharmaceutical enterprises' new drugs R&D outsourcing. So, modern pharmaceutical enterprises basing on what indexes, using what method to select the most satisfactory, or the most suitable CRO, and how to manage CRO have become inevitable issues during their new drugs R&D outsourcing. These issues require urgent solution.Based of specificly analysing the causes of the modern pharmaceutical enterprises choosing CRO, this paper establishes the indexes of modern pharmaceutical enterprises choosing CRO through literature research and logical methods, and then makes a simulation analysis on the course of modern pharmaceutical enterprises choosing CRO by the method of AHP, finally gives some measures of modern pharmaceutical enterprises manageing CRO. This research will provide the reference and guidance of indexes, method and measures with modern pharmaceutical enterprises choosing and manageing CRO, and provide information with relevant government departments to supervise CRO as well as self-strategy management of CRO.